tirzepatide vs semaglutide differences efficacy safety GLP-1 Medications for Weight Loss: vs Retat – Revolution Health & Wellness Cardiovascular outcomes of semaglutide and

This also had an impact on sensitivity analysis 4, which adjusted for baseline HbA1c and body weight in patients on metformin in SURPASS2 and patients on metformin with or without a sulphonylurea in SUSTAIN FORTE

Careful patient selection is key to maximizing these benefits and ensuring safety

This guide has shown that while both tirzepatide and semaglutide are powerful tools for weight loss, key differences in efficacy and mechanism can make one a better choice for you

The aITC was anchored to the common comparator arm semaglutide 1 mg

however, 32% and 41% of patients in the semaglutide 2mg arm did not achieve an HbA1c target of less than 7% and weight loss of at least 5%, respectively

The milligrams are different because the mechanisms are different